Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3
PaperCitations, authors & open-access status
A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 17 citations, 2014 year and closed oa status.
17
Citations
2014
Year
closed
OA Status